Please provide your email address to receive an email when new articles are posted on . The FDA has approved a new autoinjector pen option for Cyltezo, an interchangeable biosimilar to Humira. Cyltezo ...
As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
(Reuters) -Amgen Inc said on Tuesday it launched a biosimilar version of AbbVie Inc's big selling arthritis treatment, the first such competition for Humira in the United States. Amgen said its drug, ...
Jan 31 (Reuters) - Amgen Inc (AMGN.O), opens new tab said on Tuesday it launched a biosimilar version of AbbVie Inc's (ABBV.N), opens new tab big selling arthritis treatment, the first such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results